JANE STREET GROUP, LLC - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$4,332,559
-6.0%
64,511
-5.2%
0.00%
-50.0%
Q2 2023$4,608,816
+147.3%
68,067
+97.6%
0.00%
+100.0%
Q1 2023$1,863,907
-16.1%
34,453
-7.3%
0.00%0.0%
Q4 2022$2,222,062
+2.9%
37,152
-22.2%
0.00%0.0%
Q3 2022$2,159,000
-77.1%
47,743
-71.6%
0.00%
-75.0%
Q2 2022$9,425,000
-9.0%
168,167
+15.5%
0.00%
+33.3%
Q1 2022$10,357,000
-27.5%
145,656
-33.5%
0.00%
-40.0%
Q4 2021$14,285,000
+25.1%
218,911
+43.8%
0.01%0.0%
Q3 2021$11,421,000
+401.4%
152,203
+421.4%
0.01%
+400.0%
Q2 2021$2,278,000
-14.7%
29,193
-10.5%
0.00%
-50.0%
Q1 2021$2,672,000
+5.2%
32,630
+6.2%
0.00%
+100.0%
Q4 2020$2,540,000
-74.7%
30,717
-80.2%
0.00%
-83.3%
Q3 2020$10,057,000
+764.0%
154,782
+723.3%
0.01%
+500.0%
Q2 2020$1,164,000
-66.8%
18,800
-65.7%
0.00%
-75.0%
Q1 2020$3,509,000
+607.5%
54,801
+665.6%
0.00%
+300.0%
Q4 2019$496,000
+8.8%
7,158
-0.5%
0.00%0.0%
Q2 2019$456,000
+9.9%
7,194
+1.3%
0.00%0.0%
Q1 2019$415,000
-37.6%
7,101
-34.1%
0.00%0.0%
Q4 2018$665,000
+13.3%
10,775
+43.1%
0.00%0.0%
Q3 2018$587,000
-96.2%
7,528
-96.7%
0.00%
-97.2%
Q2 2018$15,331,000226,3890.04%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q3 2020
NameSharesValueWeighting ↓
BARINGTON CAPITAL GROUP, L.P. 76,809$4,155,3675.68%
Paradice Investment Management LLC 850,583$46,016,5403.50%
BERNZOTT CAPITAL ADVISORS 273,702$14,807,2783.06%
Orchard Capital Management, LLC 135,466$7,328,7112.45%
Advantage Alpha Capital Partners LP 202,232$10,940,7512.28%
REINHART PARTNERS, LLC. 746,588$40,390,4192.19%
Magnetar Financial LLC 1,917,030$103,711,3232.02%
Leeward Investments, LLC - MA 700,894$37,918,3651.73%
HEARTLAND ADVISORS INC 505,204$27,331,5361.69%
Copeland Capital Management, LLC 1,226,985$66,3801.56%
View complete list of ENCOMPASS HEALTH CORP shareholders